SCHEMBL4883512

SCHEMBL4883512

Cc1ccc(Oc2c[nH]nc2-c2ccc(O)cc2O)c(C)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.42
ALDH1A1 P00352 1/20 0.42
POLB P06746 1/20 0.42
MAPT P10636 6/20 0.41
KMT2A Q03164 5/20 0.41
MEN1 O00255 4/20 0.41
ALOX12 P18054 4/20 0.41
GPR55 Q9Y2T6 3/20 0.41
HTT P42858 3/20 0.41
HIF1A Q16665 1/20 0.41
GAA P10253 6/20 0.41
AMY1A P0DUB6 1/20 0.40
HSP90AA1 P07900 1/20 0.38
ESR1 P03372 2/20 0.38
CNR1 P21554 1/20 0.37
CNR2 P34972 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4877184 0.90 KMT2A (0.44) LMNAALDH1A1POLBMAPTKMT2A
SCHEMBL4875807 0.87 LMNA (0.40) LMNAALDH1A1POLBMAPTKMT2A
SCHEMBL4881715 0.85 KMT2A (0.48) LMNAALDH1A1POLBMAPTKMT2A
SCHEMBL4879366 0.85 KMT2A (0.40) LMNAALDH1A1POLBMAPTKMT2A
SCHEMBL4883601 0.84 MEN1 (0.51) LMNAALDH1A1POLBMAPTKMT2A
SCHEMBL4881078 0.82 HSP90AA1 (0.40) LMNAMAPTGAAHSP90AA1ESR1
SCHEMBL4881990 0.81 MAPT (0.46) LMNAALDH1A1POLBMAPTKMT2A
SCHEMBL4884200 0.81 MAPT (0.49) LMNAALDH1A1POLBMAPTKMT2A
SCHEMBL4877787 0.81 KMT2A (0.43) LMNAALDH1A1POLBMAPTKMT2A
SCHEMBL4883552 0.80 KMT2A (0.48) LMNAALDH1A1POLBMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1799649-B1 3-(2-HYDROXYPHENYL) PYRAZOLES AND THEIR USE AS HSP90 MODULATORS MERCK PATENT GMBH (DE) 2014-06-25 EP claimed
US-20080090880-A1 3-(2-Hydroxyphenyl) Pyrazoles and Thier Use as Hsp90 Modulators MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2008-04-17 US claimed
EP-1799649-B1 3-(2-HYDROXYPHENYL) PYRAZOLES AND THEIR USE AS HSP90 MODULATORS MERCK PATENT GMBH (DE) 2014-06-25 EP disclosed
US-20080090880-A1 3-(2-Hydroxyphenyl) Pyrazoles and Thier Use as Hsp90 Modulators MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2008-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090880-A1 3-(2-Hydroxyphenyl) Pyrazoles and Thier Use as Hsp90 Modulators HSP90AB1, HSP90AA1, HSP90AB2P LMNA 4229/4885ALDH1A1 1963/4885POLB 3543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.